panitumumab (vectibix) Report issue

Biologics mAb Approved FDA Accelerated Approval FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH repoDB
Back

Drug Pricing Summary

AUS PBS

$367.5930 - $1470.3487

VA Big4

$858.8900 - $3442.7500

VA FSS

$1216.8000 - $4867.2000

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
panitumumab 100 mg / 5 mL (INJECTION) $367.5930 AUS PBS generic
  • Vectibix (1)
    		•  Amgen Australia Pty Limited
    panitumumab 100 mg / 5 mL (5 mL SOLUTION) $858.8900 VA Big4
  • Vectibix (1)
    		•  Amgen USA, Inc.
    panitumumab 100 mg / 5 mL (5 mL SOLUTION) $1216.8000 VA FSS
  • Vectibix (1)
    		•  Amgen USA, Inc.
    panitumumab 400 mg / 20 mL (INJECTION) $1470.3487 AUS PBS generic
  • Vectibix (1)
    		•  Amgen Australia Pty Limited
    panitumumab 400 mg / 20 mL (20 mL SOLUTION) $3442.7500 VA Big4
  • Vectibix (1)
    		•  Amgen USA, Inc.
    panitumumab 400 mg / 20 mL (20 mL SOLUTION) $4867.2000 VA FSS
  • Vectibix (1)
    		•  Amgen USA, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue